Free Trial
NASDAQ:CERT

Certara (CERT) Stock Price, News & Analysis

Certara logo
$11.33 -0.16 (-1.39%)
Closing price 07/3/2025 03:45 PM Eastern
Extended Trading
$11.33 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Certara Stock (NASDAQ:CERT)

Key Stats

Today's Range
$11.19
$11.50
50-Day Range
$10.46
$14.17
52-Week Range
$8.64
$16.93
Volume
1.28 million shs
Average Volume
1.45 million shs
Market Capitalization
$1.84 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.71
Consensus Rating
Moderate Buy

Company Overview

Certara Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

CERT MarketRank™: 

Certara scored higher than 95% of companies evaluated by MarketBeat, and ranked 172nd out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Certara has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 5 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Certara has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Certara's stock forecast and price target.
  • Earnings Growth

    Earnings for Certara are expected to grow by 28.57% in the coming year, from $0.28 to $0.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Certara is -566.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Certara is -566.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Certara has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Certara's valuation and earnings.
  • Percentage of Shares Shorted

    7.49% of the float of Certara has been sold short.
  • Short Interest Ratio / Days to Cover

    Certara has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Certara has recently increased by 7.69%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Certara does not currently pay a dividend.

  • Dividend Growth

    Certara does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.49% of the float of Certara has been sold short.
  • Short Interest Ratio / Days to Cover

    Certara has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Certara has recently increased by 7.69%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Certara has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Certara this week, compared to 5 articles on an average week.
  • Search Interest

    6 people have searched for CERT on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Certara to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Certara insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.33% of the stock of Certara is held by insiders.

  • Percentage Held by Institutions

    73.96% of the stock of Certara is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Certara's insider trading history.
Receive CERT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Certara and its competitors with MarketBeat's FREE daily newsletter.

CERT Stock News Headlines

Certara (NASDAQ:CERT) Coverage Initiated by Analysts at Morgan Stanley
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.
Barclays Upgrades Certara (CERT)
See More Headlines

CERT Stock Analysis - Frequently Asked Questions

Certara's stock was trading at $10.65 on January 1st, 2025. Since then, CERT stock has increased by 6.4% and is now trading at $11.33.

Certara, Inc. (NASDAQ:CERT) announced its quarterly earnings results on Monday, May, 5th. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.04. Certara's quarterly revenue was up 9.7% on a year-over-year basis.
Read the conference call transcript
.

Certara (CERT) raised $500 million in an IPO on Friday, December 11th 2020. The company issued 24,400,000 shares at $19.00-$22.00 per share. Jefferies, Morgan Stanley, BofA Securities, Credit Suisse, Barclays and William Blair acted as the underwriters for the IPO.

Shares of CERT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Certara investors own include CRISPR Therapeutics (CRSP), Pure Storage (PSTG), Opendoor Technologies (OPEN), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
5/05/2025
Today
7/04/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CERT
Fax
N/A
Employees
350
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.71
High Stock Price Target
$18.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+38.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.56
Research Coverage
9 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
40.46
P/E Growth
N/A
Net Income
-$12.05 million
Pretax Margin
-1.83%

Debt

Sales & Book Value

Annual Sales
$385.15 million
Cash Flow
$0.71 per share
Price / Cash Flow
15.97
Book Value
$6.58 per share
Price / Book
1.72

Miscellaneous

Free Float
158,454,000
Market Cap
$1.84 billion
Optionable
Optionable
Beta
1.43
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:CERT) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners